Research Article
Serum Amyloid A as a Marker of Persistent Inflammation and an Indicator of Cardiovascular and Renal Involvement in Patients with Rheumatoid Arthritis
Table 1
Baseline characteristics of 140 RA patients.
| | Variable | Results |
| | Demographic variables | | | Age (years) | 50.3 (10.9) (range 18–76) | | Gender (F/M) | 111 (79.3%)/29 (20.7%) | | RA related variables | | | Disease duration (years) | 10.1 (7.5) (range 0.5–33) | | RA duration >10 years | 64 (45.7%) | | RF-IgM positivity | 99 (70.7%) | | ACPA positivity | 116 (82.9%) | | Erosions | 117 (84%) | | Extra-articular symptoms | 58 (41.4%) | | DAS28 | 4.52 (1.31) (range 1.9–8.5) | | DAS28 ≤ 5.1 | 98 (70%) | | DAS28 < 2.6 | 8 (5.7%) | | M-HAQ | 1.25 (0.62) (range 0–2.75) | | Current MTX usage | 82 (58.6%) | | Current GC usage | 108 (77.1%) | | Current biologic therapy | 36 (25.7%) |
|
|
Values are mean (SD) or numbers (%).
RF-IgM: rheumatoid factor IgM; ACPA: anticitrullinated protein antibodies; DAS: Disease Activity Score; M-HAQ: Modified Health Assessment Questionnaire; MTX: methotrexate; GC: glucocorticoid.
|
